Vir Biotechnology, Inc. (VIR)

Vir Biotechnology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	222.95	241.58	848.63	347.82	436.58
Short-Term Investments	682.4	1,281	1,553	360.33	300.29
Cash & Short-Term Investments	905.35	1,522	2,402	708.15	736.86
Cash Growth	-40.53%	-36.62%	239.20%	-3.90%	92.17%
Accounts Receivable	-	-	-	773.08	-
Other Receivables	5.1	11.6	28.9	-	1.9
Receivables	5.1	11.6	28.9	773.08	1.9
Prepaid Expenses	42.63	40.95	57.84	73	25.61
Restricted Cash	89.39	13.27	12.68	8.59	7.99
Other Current Assets	-	-	17.62	-	-
Total Current Assets	1,042	1,588	2,519	1,563	772.37
Property, Plant & Equipment	122.86	167.2	188.17	130.05	79.89
Long-Term Investments	190.02	105.28	23.93	201.39	-
Goodwill	16.94	16.94	16.94	16.94	16.94
Other Intangible Assets	8.12	22.57	32.76	33.29	33.82
Other Long-Term Assets	18.42	18.86	21.23	9.78	15.75
Total Assets	1,399	1,919	2,802	1,954	918.76
Accounts Payable	5.08	6.33	6.42	6.52	5.08
Accrued Expenses	66.53	82.15	462.07	129.54	69.84
Current Portion of Leases	7.75	12.87	4.14	3.93	3.63
Current Income Taxes Payable	-	-	15.23	6.22	-
Current Unearned Revenue	12.65	64.85	15.52	98.21	6.45
Other Current Liabilities	27.65	9.2	7.65	96.83	14.07
Total Current Liabilities	119.66	175.41	511.03	341.24	99.06
Long-Term Leases	90.14	111.67	123.84	133.56	66.56
Long-Term Unearned Revenue	-	-	53.21	3.82	3.82
Long-Term Deferred Tax Liabilities	-	-	-	18.44	3.25
Other Long-Term Liabilities	38.63	41.74	36.05	25.36	29.22
Total Liabilities	248.43	328.82	724.13	522.42	201.91
Common Stock	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	1,912	1,829	1,710	1,572	1,385
Retained Earnings	-759.78	-237.82	377.24	-138.6	-667.18
Comprehensive Income & Other	-1.72	-0.82	-9.12	-1.1	-1.28
Total Common Equity	1,150	1,590	2,078	1,432	716.85
Shareholders' Equity	1,150	1,590	2,078	1,432	716.85
Total Liabilities & Equity	1,399	1,919	2,802	1,954	918.76
Total Debt	97.89	124.54	127.97	137.49	70.18
Net Cash (Debt)	807.46	1,398	2,274	570.66	666.68
Net Cash Growth	-42.24%	-38.53%	298.50%	-14.40%	73.98%
Net Cash Per Share	5.93	10.42	16.87	4.28	5.59
Filing Date Shares Outstanding	137.14	135.03	133.53	132.3	127.84
Total Common Shares Outstanding	136.96	134.78	133.24	131.16	127.42
Working Capital	922.8	1,413	2,008	1,222	673.3
Book Value Per Share	8.40	11.80	15.60	10.92	5.63
Tangible Book Value	1,125	1,551	2,028	1,382	666.1
Tangible Book Value Per Share	8.22	11.51	15.22	10.53	5.23
Machinery	44.9	49.4	41.93	22.57	18.77
Construction In Progress	1.07	0.23	-	26.93	1.14
Leasehold Improvements	53.99	80.29	84.42	7.83	7.27

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q